Buy NM-2201 Analysis Chemicals Online

NM-2201 (often known as CBL-2201) is an synthetic cannabinoid (indole-based mostly) that has related properties to the closely related 5F-PB-22 and NNE1. NM2201 is an analog of AM2201, the potent artificial cannabinoid. NM-220 is both full agonists and unselectively bind to CB1 and CB2 (0.332 nM at CB1 and 0.732 nM at CB2) receptors with low nanomolar affinity.

MDMB-CHMINACA is an indazole-primarily based synthetic cannabinoid that acts as a potent agonist of the CB₁ receptor, and has been bought on-line as a designer drug. It was invented by Pfizer in 2008, 4F-PV8 Kristall and is some of the potent cannabinoid agonists identified, with a binding affinity of 0.0944 nM at CB₁, and an EC₅₀ of 0.330 nM

For artspace auctions winning bidders are charged a 15% purchaser’s premium on high of the hammer value. In no circumstances will artspace place a bid that’s above the reserve value. When you’re outbid, the system robotically bids in your behalf in response to the bidding increments established for that public sale as much as (but by no means exceeding) your most bid.

Comments are closed.